Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. S. Danielson
The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Related publications
The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Aberrant Activation of ALK Kinase by a Novel Truncated Form ALK Protein in Neuroblastoma
Oncogene
Cancer Research
Genetics
Molecular Biology
NeuroD1 Promotes Neuroblastoma Cell Growth by Inducing the Expression of ALK
Cancer Science
Cancer Research
Medicine
Oncology
Repotrectinib (TPX-0005), Effectively Reduces Growth of ALK Driven Neuroblastoma Cells
Scientific Reports
Multidisciplinary
ALK in Neuroblastoma: Biological and Therapeutic Implications
Cancers
Cancer Research
Oncology
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
Glutathione Biosynthesis Is Upregulated at the Initiation of MYCN-driven Neuroblastoma Tumorigenesis
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Sweyjawbu Expression Is a Predictor of ALK Rearrangement Status in Lymphoma
Oncotarget
Oncology
ALK Is a Critical Regulator of the MYC-signaling Axis in ALK Positive Lung Cancer
Oncotarget
Oncology